Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Watch Ingenta (ING) by Steve Moore in ShareProphets
- Avoid Videndum (VID) by Steve Moore in ShareProphets
- Watch Funding Circle Holdings (FCH) by Mark Hartley in The Motley Fool
- Sell Dr. Martens (DOCS) by Steve Moore in ShareProphets
- Hold Persimmon (PSN) by Berenberg
- Buy Atalaya Mining (ATYM) by Berenberg
- Buy Alfa Financial Software Holdings (ALFA) by Berenberg
- Avoid British American Tobacco (BATS) by Royston Wild in The Motley Fool
- Avoid BP (BP.) by Royston Wild in The Motley Fool
- Avoid BT Group (BT.A) by Royston Wild in The Motley Fool
- Buy RS Group (RS1) by John Ficenec in The Times - Tempus
- Buy Johnson Matthey (JMAT) by Jefferies
- Hold Zigup (ZIG) by Jefferies
- Watch Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Forterra (FORT) by Jefferies
- Buy Conduit Holdings Limited Com Shs (DI) (CRE) by Jefferies
- Buy Intermediate Capital Group (ICG) by Jefferies
- Buy Rolls-Royce Holdings (RR.) by Jefferies
- Buy Persimmon (PSN) by Jefferies
- Avoid Forterra (FORT) by Steve Moore in ShareProphets
GSK (GSK) Share Price
Health Care Sector
NOTE: This is based on 1,474 open tips for GSK (GSK)
| Latest Bid : 1,915.00p | Latest Ask : 1,916.00p |
| High Today : 1,921.00p | Low Today : 1,892.00p |
| This Years High : 2,208.00p | This Years Low : 1,735.50p |
| Volume : 1,259,414 | MKT Cap : £79231.68M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
GSK (GSK) Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.GSK (GSK) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Robert Stephens (The Times) | Premium Only | 2026-11-09 09:20:00 09/11/2026 | 0.63% |
| Buy | Berenberg | Premium Only | 2026-11-03 10:50:00 03/11/2026 | 4.20% |
| Hold | Deutsche Bank | Premium Only | 2026-10-29 14:45:00 29/10/2026 | 5.67% |
| Hold | Jefferies | Premium Only | 2026-10-29 10:40:00 29/10/2026 | 5.90% |
| Buy | Jefferies | Premium Only | 2026-10-20 13:30:00 20/10/2026 | 2.80% |
GSK (GSK) Recent Short Position Updates
| Position | Date |
|---|---|
| 1.06% | 04/11/2026 |
| Latest Bid : 1,915.00p | Latest Ask : 1,916.00p |
| High Today : 1,921.00p | Low Today : 1,892.00p |
| This Years High : 2,208.00p | This Years Low : 1,735.50p |
| Volume : 1,259,414 | MKT Cap : £79231.68M |
GSK Overview
We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of 2030. Our bold ambitions for patients are reflected in commitments to growth and a step-change in performance. We are a company where outstanding people can thrive.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest GSK Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Buy | Robert Stephens (The Times) | Premium Only | 2026-11-09 09:20:00 09/11/2026 | 0.63% |
| Buy | Berenberg | Premium Only | 2026-11-03 10:50:00 03/11/2026 | 4.20% |
| Hold | Deutsche Bank | Premium Only | 2026-10-29 14:45:00 29/10/2026 | 5.67% |
| Hold | Jefferies | Premium Only | 2026-10-29 10:40:00 29/10/2026 | 5.90% |
| Buy | Jefferies | Premium Only | 2026-10-20 13:30:00 20/10/2026 | 2.80% |